Inventor · disambiguated record
Dong Woo Song
Also filed as: SONG DONG WOO
10 granted patents·7 pending applications·6 citations·filing 2011–2025
80Inventor score
Top patents by PatentIndex Score
17 records- 0183US8716701B2Method and apparatus for providing a charge blocking layer on an infrared up-conversion deviceSO FRANKY·Filed 2011·Granted May 6, 2014·5 cites·42 claims
- 0274US12486521B2Platform for expressing protein of interest in liverTOOLGEN INC·Filed 2023·Granted Dec 2, 2025·0 cites·13 claims
- 0369US12163149B2Artificial genome manipulation for gene expression regulationTOOLGEN INC·Filed 2022·Granted Dec 10, 2024·0 cites·5 claims
- 0466US11999952B2Artificially-manipulated neovascularization regulatory systemTOOLGEN INC·Filed 2021·Granted Jun 4, 2024·0 cites·11 claims
- 0566US9997571B2Method and apparatus for providing a charge blocking layer on an infrared up-conversion deviceUNIV FLORIDA·Filed 2014·Granted Jun 12, 2018·1 cites·26 claims
- 0661US2025115906A1Schwann cell-specific promoterTOOLGEN INC·Filed 2023·Application pending·0 cites
- 0760US11572574B2Artificial genome manipulation for gene expression regulationTOOLGEN INC·Filed 2020·Granted Feb 7, 2023·0 cites·15 claims
- 0860US2023190889A1Gene editing of anticoagulant factorsTOOLGEN INC·Filed 2023·Application pending·0 cites
- 0958US11667934B2Platform for expressing protein of interest in liverTOOLGEN INC·Filed 2018·Granted Jun 6, 2023·0 cites·15 claims
- 1054US2025051749A1Novel promoter and use thereofTOOLGEN INC·Filed 2022·Application pending·0 cites
- 1153US12331086B2Artificially engineered SC function control systemTOOLGEN INC·Filed 2017·Granted Jun 17, 2025·0 cites·5 claims
- 1248US12480098B1Adeno-associated virus variantAAVATAR THERAPEUTICS CO LTD·Filed 2025·Granted Nov 25, 2025·0 cites·18 claims
- 1348US2018237771A1Artificially-Manipulated Neovascularization Regulatory SystemTOOLGEN INC·Filed 2018·Application pending·0 cites
- 1445US11845951B2Gene manipulation for treatment of retinal dysfunction disorderTOOLGEN INC·Filed 2018·Granted Dec 19, 2023·0 cites·10 claims
- 1544US2021317448A1Gene editing of anticoagulantsTOOLGEN INC·Filed 2019·Application pending·0 cites
- 1642US2022192163A1Hemophilia b rat modelTOOLGEN INC·Filed 2020·Application pending·0 cites
- 1741US2020263204A1Composition for treating hemophilia a by crispr/cas system of reverting fviii gene inversionTOOLGEN INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →